- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03217682
Impact of Massage Therapy and Music Therapy on the Quality of Life of Hospice Patients
May 4, 2022 updated by: Maria I. Lapid, M.D., Mayo Clinic
This is a cohort study where subjects will receive either massage therapy or music therapy interventions to evaluate their impact on hospice patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
There is growing evidence that integrative therapies such as massage therapy and music therapy can be effective therapeutic tools for relief of pain and non-pain symptoms in hospice and palliative care patients.
Massage and music therapies can provide comfort, relaxation, and improve quality of life for patients.
The investigator's primary aim is to compare the effects of massage and music therapies on the quality of life of hospice patients.
The overall goal is to further improve pain, depression, anxiety, and poor well-being or quality of life in hospice patients through the use of integrative therapies, specifically massage and music therapies, as add-on to standard hospice clinical care.
Patients will be assigned to either the massage therapy or music therapy cohort.
Questionnaires will be utilized before and after each massage or music therapy intervention to quantify symptom and quality of life levels.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient is currently enrolled in Mayo Clinic Hospice
- Age 18 years or older
- ESAS-r scores of 5 or greater on pain, depression, anxiety, or best well-being (clinical assessment by hospice nursing staff)
- Patient or caregiver must be able to participate in brief interviews and complete questionnaires (verbally or physically)
Exclusion Criteria:
- Patients that would not be able to get a massage due to complexity of medical care including complex wound and multiple drains
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Music Therapy
Music therapy twice a week for two weeks, each session lasting approximately 45 min-1 hr
|
Music therapy sessions
|
|
Experimental: Massage Therapy
Massage therapy twice a week for two weeks, each session lasting approximately 45 min-1 hr
|
Massage therapy sessions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Edmonton Symptom Assessment System - Revised
Time Frame: Baseline to 3 weeks
|
The primary endpoints are patient pain, depression, anxiety and wellbeing as measured by ESAS-r.
Pro-rated area under the curve (AUC) statistics will be calculated for all individual items and total scores.
The pro-rated AUC for ESAS-r measured pain, depression, anxiety, and wellbeing will all be utilized individually to assess the primary endpoint.
The pro-rated AUC will be compared to the assessment score prior to any massage or music therapy.
If there is any improvement, the therapy will be considered a success since any improvement will be seen as beneficial.
|
Baseline to 3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Edmonton Symptom Assessment System - Revised (Other symptoms)
Time Frame: Baseline to 3 weeks
|
Secondary endpoints include all other symptoms (tiredness, drowsiness, nausea, lack of appetite, shortness of breath) as measured by the ESAS-r.
Similar analysis will be conducted for all other endpoints as was conducted for the primary outcome.
Pro-rated area under the curve (AUC) statistics will be calculated for all individual items and total scores.
|
Baseline to 3 weeks
|
|
Change in Linear Analogue Self Assessment (LASA)
Time Frame: Baseline to 3 weeks
|
Secondary endpoints include symptoms as measured by the LASA (overall quality of life [QOL], mental well-being, physical well-being, emotional well-being, social activity, spiritual well-being, pain frequency, pain severity, fatigue, and social support).
LASA items are stand alone, thus no scoring is necessary, but individual LASA items may be transposed so lower scores mean worse symptoms and higher scores mean less symptoms.
This will allow consistency and thus easier data interpretation.
Pro-rated area under the curve (AUC) statistics will be calculated for all individual items and total scores.
Similar analysis will be conducted for all other endpoints as was conducted for the primary outcome.
|
Baseline to 3 weeks
|
|
Change in Patient Health Questionnaire for Depression and Anxiety (PHQ-4)
Time Frame: Baseline to 3 weeks
|
Secondary endpoints include depression and anxiety symptoms as measured by the PHQ-4.
Similar analysis will be conducted for all other endpoints as was conducted for the primary outcome.
|
Baseline to 3 weeks
|
|
Change in Pearlin role overload measure (ROM)
Time Frame: Baseline to 3 weeks
|
Secondary endpoints include caregiver stress as measured by the ROM.
Pro-rated area under the curve (AUC) statistics will be calculated for all individual items and total scores.
Similar analysis will be conducted for all other endpoints as was conducted for the primary outcome.
|
Baseline to 3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 4, 2017
Primary Completion (Actual)
March 11, 2022
Study Completion (Actual)
March 11, 2022
Study Registration Dates
First Submitted
July 12, 2017
First Submitted That Met QC Criteria
July 12, 2017
First Posted (Actual)
July 14, 2017
Study Record Updates
Last Update Posted (Actual)
May 10, 2022
Last Update Submitted That Met QC Criteria
May 4, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 17-002950
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Music Therapy
-
Case Comprehensive Cancer CenterCompletedMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedAutonomic Nervous System Imbalance | Hypothalamic Pituitary Adrenal Axis SuppressionUnited States
-
University of PennsylvaniaConestoga High SchoolCompletedStress | Cognitive Impairment | DementiaUnited States
-
Wayne State UniversityCompletedNeurological DisordersUnited States
-
Icahn School of Medicine at Mount SinaiCompletedSARS-CoV 2 | Dyspnea | Post Covid-19 RespiratoryUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
Children's Healthcare of AtlantaCompletedRespiratory Syncytial Virus InfectionsUnited States
-
University of MilanUnknownCritical Illness | Music Therapy | Hypnotics and SedativesItaly
-
Beth Israel Medical CenterCompleted
-
Inge Nygaard PedersenAalborg UniversityUnknown